YY1 lactylation mediates epithelial barrier dysfunction during acute lung injury [0.03%]
YY1乳化作用在急性肺损伤上皮屏障功能障碍中的作用
Ning Li,Yi Liu,Minglang Gao et al.
Ning Li et al.
Elevated lactate levels in lung tissue are a distinct hallmark of acute lung injury (ALI), but the biological functions of glycolytic reprogramming and lactate-derived protein modification in damaged alveolar epithelial cells remain poorly ...
Postural relief of dyspnoea in advanced COPD: a step towards personalised symptom management [0.03%]
终末期COPD患者呼吸困难的体位缓解：迈向个体化症状管理的第一步
Pierantonio Laveneziana,Matthieu Le Mélédo,Kyle Geoffrey P J M Boyle
Pierantonio Laveneziana
Reply to: The use of spirometry to define airflow obstruction and diagnose COPD [0.03%]
对“应用肺功能判断气流受限及诊断慢阻肺”的述评
David M G Halpin,Sanja Stanojevic
David M G Halpin
Opioids for persistent dyspnoea in people with COPD: should we throw in the towel? [0.03%]
长效阿片类药物能否改善慢性阻塞性肺疾病患者的持续性呼吸困难？放弃还是坚持？
Jean Bourbeau,David Currow
Jean Bourbeau
Persisting breathlessness after acute pulmonary embolism, a systematic SEARCH [0.03%]
持续性肺栓塞后呼吸困难的系统性SEARCH研究
Marion Delcroix,Laura Hardy
Marion Delcroix
The use of spirometry to define airflow obstruction and diagnose COPD [0.03%]
使用肺功能测定法定义气流阻塞并诊断慢性阻塞性肺病
Peter Burney,Ben Knox-Brown,André Amaral
Peter Burney
The recent statement from GOLD/GLI on the use of spirometry is insufficient, particularly in the global South https://bit.ly/4nx13qw
Shining light on a dark prognosis: prognostic factors in pulmonary hypertension associated with interstitial lung disease [0.03%]
拨开与间质性肺疾病相关肺动脉高压预后因素的迷雾
Jason Weatherald,Nathan Hambly
Jason Weatherald
Youth vaping in Europe: nicotine regulation needs respiratory end-points [0.03%]
欧洲青年吸食电子烟：尼古丁监管需要呼吸系统指标
Jack Allen,Síle Toland
Jack Allen
Steven Baylis,Nicholas S Hopkinson,Ariadna Feliu et al.
Steven Baylis et al.
A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with chronic obstructive pulmonary disease [0.03%]
慢性阻塞性肺疾病患者中髓过氧化物酶抑制剂米替哌斯特的2期双盲随机安慰剂对照试验
Dinesh Saralaya,M Nubli Mustapa,João Ferreira et al.
Dinesh Saralaya et al.
Background: Neutrophilic inflammation is a common feature of chronic obstructive pulmonary disease (COPD). Mitiperstat, an inhibitor of myeloperoxidase expressed in neutrophils, may have potential as a COPD treatment. ...